The Optimal Timing of Breast Cancer Surgery After COVID-19 Infection: an Observational Study

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2024 Nov 4

PMID 39491038

Authors

Zhao Bi

Wei-Hao Cheng

Wen-Hao Zheng

Tong-Yue Ren

Peng Chen

Yan-Bing Liu

Peng-Fei Qiu

Wei-Li Wang

Yong-Sheng Wang

Affiliations

Soon will be listed here.

Abstract

Purpose: It is controversial for the optimal time of breast cancer surgery after COVID-19 infection. Purpose was to assess the risk of postoperative complication in breast cancer patients with COVID-19 infection, in order to select optimal surgery timing after COVID-19 infection.

Methods: Breast cancer patients infected with COVID-19 and performed surgery between December 20th, 2022 to March 20th, 2023 were included in this prospective study (n = 577). Patients performed surgery between May 1, 2019 to October 1, 2019 were listed as control group (n = 329). They had not been infected with COVID-19 before surgery. Patients were grouped by time of surgery relative to COVID-19 infection. Database was evaluated using logistic regression.

Results: Patients infected with COVID-19 had a higher incidence of complications after surgery compared to that not-COVID-19 infection (6.59% vs. 3.04%). Multivariable logistic analysis demonstrated that timing of surgery was associated with complications (OR = 4.253; 95% CI: 0.855-21.153, P = 0.044). Patients performed surgery within 2 weeks after COVID-19 infection had the highest rates of complication (17.65%) when compared with other groups, while the incidence was decreased into 5.51% when surgery 2 weeks or more after COVID-19 infection. With a median follow-up was 10 months, all patients with complications were recovered without serious complications or death, which had no adverse effect on subsequent anti-tumor therapy.

Conclusions: It needs to be cautious when breast cancer surgery was performed within 2 weeks after COVID-19 infection. Although the incidence of complications in patients undergoing surgery 2 weeks after COVID-19 infection is still slightly high, surgery might be recommended considering urgency of treatment, good prognosis of complications and the lack of influence on subsequent adjuvant therapy.

References

Aminian A, Safari S, Razeghian-Jahromi A, Ghorbani M, Delaney C . COVID-19 Outbreak and Surgical Practice: Unexpected Fatality in Perioperative Period. Ann Surg. 2020; 272(1):e27-e29. PMC: 7188030. DOI: 10.1097/SLA.0000000000003925. View

Klemen N, Feingold P, Hashimoto B, Wang M, Kleyman S, Brackett A . Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis. Lancet Haematol. 2020; 7(8):e583-e593. DOI: 10.1016/S2352-3026(20)30211-8. View

Deng J, Chan J, Potter A, Chen Y, Sandhu H, Panda N . The Risk of Postoperative Complications After Major Elective Surgery in Active or Resolved COVID-19 in the United States. Ann Surg. 2021; 275(2):242-246. PMC: 8745943. DOI: 10.1097/SLA.0000000000005308. View

. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020; 396(10243):27-38. PMC: 7259900. DOI: 10.1016/S0140-6736(20)31182-X. View

Ranganathan P, Salunke B, Wajekar A, Siddique A, Daruwalla K, Chawathey S . Outcomes of elective cancer surgery in COVID-19 survivors: An observational study. J Surg Oncol. 2022; 127(1):11-17. PMC: 9538405. DOI: 10.1002/jso.27095. View

Karmakar M, Lantz P, Tipirneni R . Association of Social and Demographic Factors With COVID-19 Incidence and Death Rates in the US. JAMA Netw Open. 2021; 4(1):e2036462. PMC: 7846939. DOI: 10.1001/jamanetworkopen.2020.36462. View

Pastori D, Cormaci V, Marucci S, Franchino G, Del Sole F, Capozza A . A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology. Int J Mol Sci. 2023; 24(4). PMC: 9964264. DOI: 10.3390/ijms24043169. View

Liang W, Guan W, Chen R, Wang W, Li J, Xu K . Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21(3):335-337. PMC: 7159000. DOI: 10.1016/S1470-2045(20)30096-6. View

Tran B, Nguyen T, Hwang B, Vidar E, Davis G, Chan L . Risk factors associated with venous thromboembolism in 49,028 mastectomy patients. Breast. 2013; 22(4):444-8. DOI: 10.1016/j.breast.2013.04.018. View

10.

. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia. 2021; 77(1):28-39. PMC: 8652887. DOI: 10.1111/anae.15563. View

11.

Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F . SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022; 7(1):141. PMC: 9047469. DOI: 10.1038/s41392-022-00997-x. View

12.

Sgarzani R, Macri G, Gurrado A, Curcio A, De Lorenzi F, Galimberti V . The impact of COVID-19 pandemic on breast surgery in Italy: a multi-centric retrospective observational study. Updates Surg. 2023; 75(3):735-741. PMC: 9987352. DOI: 10.1007/s13304-023-01474-y. View

13.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

14.

Miao G, Chen Z, Cao H, Wu W, Chu X, Liu H . From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era. Biomed Pharmacother. 2023; 158:114208. PMC: 9805901. DOI: 10.1016/j.biopha.2022.114208. View

15.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

16.

Al-Hilli Z, Wilkerson A . Breast Surgery: Management of Postoperative Complications Following Operations for Breast Cancer. Surg Clin North Am. 2021; 101(5):845-863. DOI: 10.1016/j.suc.2021.06.014. View

17.

Choong G, Cullen G, OSullivan C . Evolving standards of care and new challenges in the management of HER2-positive breast cancer. CA Cancer J Clin. 2020; 70(5):355-374. DOI: 10.3322/caac.21634. View

18.

Cui L, Li N, Fu S, Zhang X, Wang X, Wang R . Combination of preoperative D-dimer and mean platelet volume predicts postoperative deep venous thrombosis in breast cancer patients. Cancer Biomark. 2017; 21(4):909-913. DOI: 10.3233/CBM-170975. View

19.

. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia. 2021; 76(6):748-758. PMC: 8206995. DOI: 10.1111/anae.15458. View

20.

Andtbacka R, Babiera G, Singletary S, Hunt K, Meric-Bernstam F, Feig B . Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg. 2005; 243(1):96-101. PMC: 1449977. DOI: 10.1097/01.sla.0000193832.40178.0a. View